Animec 18.7 mg/g Oral Paste for Horses

国: イギリス

言語: 英語

ソース: VMD (Veterinary Medicines Directorate)

有効成分:

Ivermectin

から入手可能:

Eco Animal Health Ltd

ATCコード:

QP54AA01

INN（国際名）:

Ivermectin

医薬品形態:

Oral paste

処方タイプ:

POM-VPS -Prescription Only Medicine – Veterinarian, Pharmacist, Suitably Qualified Person

治療群:

Horses

治療領域:

Endectocide

認証ステータス:

Authorized

承認日:

2008-03-12

製品の特徴

Revised: June 2023
AN: 00317/2023
Page 1 of 6
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Animec 18.7 mg/g Oral Paste for Horses
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
ACTIVE SUBSTANCE:
Ivermectin
18.7 mg/g
EXCIPIENT(S):
For a full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Oral Paste
A white homogeneous paste
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Horses
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Treatment of nematode or arthropod infection due to:
Large strongyles:
_Strongylus vulgaris_ (adults and L
4
stage larvae [arterial])
_Strongylus edentatus_ (adults and L
4
stage larvae [tissue])
_Strongylus equinus_ (adults)
Small strongyles (including benzimidazole resistant strains):
_Cyathostomum spp _(adults and luminal L
4
stage larvae)
_Cylicocyclus spp_. (adults and luminal L
4
stage larvae)
_Cylicodontophorus spp_. (adults and luminal L
4
stage larvae)
_Cylicostephanus spp_. (adults and luminal L
4
stage larvae)
_Gyalocephalus spp_. (adults and luminal L
4
stage larvae)
Ascarids:
_Parascaris equorum_ (luminal L
5
larvae and adults)
Pinworms:
_Oxyuris equi_ (L
4
stage larvae and adults)
Revised: June 2023
AN: 00317/2023
Page 2 of 6
Neck threadworms:
_Onchocerca spp_ (microfilariae)
Stomach bots:
_Gasterophilus spp_ (oral and gastric stages)
4.3
CONTRAINDICATIONS
Do not use in case of hypersensitivity to the active substance or to
any of the
excipients.
Do not use in dogs or cats as severe adverse reactions may occur.
4.4
SPECIAL WARNINGS FOR EACH TARGET SPECIES
Some horses with heavy infections of _Onchocerca_ spp. microfilariae
have
experienced oedema and pruritus following treatment, such reactions
are
assumed to be the result of death of large numbers of microfilariae.
These signs
resolve within a few days but symptomatic treatment may be advisable.
Care should be taken to avoid the following practices because they
increase the
risk of development of resistance and could ultimately result in
ineffective therapy:
•
Too frequent and repe